Additionally, we identified a novel mutant, TRIM21R443W form, and demonstrated that the R443W mutation from PRY-SPRY domain abolishes the TRIM21-mediated progression in GBM via TIF1γ/β-catenin axis. This evidence concerns the gene TRIM33 and glioblastoma.